Alterity Therapeutics (ASX:ATH) - Webinar Presentation

Company Presentations

by Finance News Network August 09, 2024 02:30 PM


Dr David Stamler - CEO - Alterity Therapeutics (ASX:ATH) is a clinical stage biotechnology company dedicated to creating an alternate future for people living with neurodegenerative diseases.

Subscribe to our Daily Newsletter?

Would you like to receive our daily news to your inbox?